Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Clonidine × Clear all

Phase

Phase 3 3 Phase 2 3 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Magnetic Resonance Spectroscopy 51 Cyclophosphamide 48 pembrolizumab 34 fludarabine 32 Radiotherapy 26 Biopsy 24 Nivolumab 22 Metformin 20 Bevacizumab 20 Fluorodeoxyglucose F18 18 Specimen Handling 17 Cisplatin 14 Radiosurgery 13 Carboplatin 13 Temozolomide 12 Paclitaxel 12 Dexamethasone 12 Fluorouracil 11 gallium 68 PSMA-11 10 durvalumab 10 Rituximab 10 Radiation 10 Letrozole 10 Gemcitabine 10 Etoposide 10 Doxorubicin 10 atezolizumab 9 X-Rays 9 Standard of Care 9 Immunotherapy, Adoptive 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04030572 2021-06-24

a2a Agonist

Weill Medical College of Cornell University

Phase EARLY_PHASE1 Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡